References
Adzhubei, I., Jordan, D. M., & Sunyaev, S. R. (2013). Predicting
functional effect of human missense mutations using PolyPhen-2. Curr
Protoc Hum Genet, Chapter 7, Unit7 20. doi:10.1002/0471142905.hg0720s76
Alsharhan, H., He, M., Edmondson, A. C., Daniel, E. J. P., Chen, J.,
Donald, T., . . . Sobering, A. K. (2021). ALG13 X-linked intellectual
disability: New variants, glycosylation analysis, and expanded
phenotypes. J Inherit Metab Dis, 44(4), 1001-1012.
doi:10.1002/jimd.12378
Amberger, J. S., Bocchini, C. A., Scott, A. F., & Hamosh, A. (2019).
OMIM.org: leveraging knowledge across phenotype-gene relationships.
Nucleic Acids Res, 47(D1), D1038-D1043. doi:10.1093/nar/gky1151
Arachchi, H., Wojcik, M. H., Weisburd, B., Jacobsen, J. O. B., Valkanas,
E., Baxter, S., . . . Rehm, H. L. (2018). matchbox: An open-source tool
for patient matching via the Matchmaker Exchange. Hum Mutat, 39(12),
1827-1834. doi:10.1002/humu.23655
Balasubramanian, M., Dingemans, A. J. M., Albaba, S., Richardson, R.,
Yates, T. M., Cox, H., . . . Kleefstra, T. (2021). Comprehensive study
of 28 individuals with SIN3A-related disorder underscoring the
associated mild cognitive and distinctive facial phenotype. Eur J Hum
Genet, 29(4), 625-636. doi:10.1038/s41431-020-00769-7
Boggan, R. M., Lim, A., Taylor, R. W., McFarland, R., & Pickett, S. J.
(2019). Resolving complexity in mitochondrial disease: Towards precision
medicine. Mol Genet Metab, 128(1-2), 19-29.
doi:10.1016/j.ymgme.2019.09.003
Bragin, E., Chatzimichali, E. A., Wright, C. F., Hurles, M. E., Firth,
H. V., Bevan, A. P., & Swaminathan, G. J. (2014). DECIPHER: database
for the interpretation of phenotype-linked plausibly pathogenic sequence
and copy-number variation. Nucleic Acids Res, 42(Database issue),
D993-D1000. doi:10.1093/nar/gkt937
Brandt, T., Sack, L. M., Arjona, D., Tan, D., Mei, H., Cui, H., . . .
Meck, J. M. (2020). Adapting ACMG/AMP sequence variant classification
guidelines for single-gene copy number variants. Genet Med, 22(2),
336-344. doi:10.1038/s41436-019-0655-2
Brnich, S. E., Abou Tayoun, A. N., Couch, F. J., Cutting, G. R.,
Greenblatt, M. S., Heinen, C. D., . . . Clinical Genome Resource
Sequence Variant Interpretation Working, G. (2019). Recommendations for
application of the functional evidence PS3/BS3 criterion using the
ACMG/AMP sequence variant interpretation framework. Genome Med, 12(1),
3. doi:10.1186/s13073-019-0690-2
Buske, O. J., Girdea, M., Dumitriu, S., Gallinger, B., Hartley, T.,
Trang, H., . . . Brudno, M. (2015). PhenomeCentral: a portal for
phenotypic and genotypic matchmaking of patients with rare genetic
diseases. Hum Mutat, 36(10), 931-940. doi:10.1002/humu.22851
Calpena, E., McGowan, S. J., Blanco Kelly, F., Boudry-Labis, E.,
Dieux-Coeslier, A., Harrison, R., . . . Wilkie, A. O. M. (2021).
Dissection of contiguous gene effects for deletions around ERF on
chromosome 19. Hum Mutat, 42(7), 811-817. doi:10.1002/humu.24213
Campbell, P., Ellingford, J. M., Parry, N. R. A., Fletcher, T., Ramsden,
S. C., Gale, T., . . . Sergouniotis, P. I. (2019). Clinical and genetic
variability in children with partial albinism. Sci Rep, 9(1), 16576.
doi:10.1038/s41598-019-51768-8
Chatzimichali, E. A., Brent, S., Hutton, B., Perrett, D., Wright, C. F.,
Bevan, A. P., . . . Swaminathan, G. J. (2015). Facilitating
collaboration in rare genetic disorders through effective matchmaking in
DECIPHER. Hum Mutat, 36(10), 941-949. doi:10.1002/humu.22842
Church, D. M., Lappalainen, I., Sneddon, T. P., Hinton, J., Maguire, M.,
Lopez, J., . . . Flicek, P. (2010). Public data archives for genomic
structural variation. Nat Genet, 42(10), 813-814. doi:10.1038/ng1010-813
Deciphering Developmental Disorders, S. (2017). Prevalence and
architecture of de novo mutations in developmental disorders. Nature,
542(7642), 433-438. doi:10.1038/nature21062
den Dunnen, J. T., Dalgleish, R., Maglott, D. R., Hart, R. K.,
Greenblatt, M. S., McGowan-Jordan, J., . . . Taschner, P. E. (2016).
HGVS Recommendations for the Description of Sequence Variants: 2016
Update. Hum Mutat, 37(6), 564-569. doi:10.1002/humu.22981
Ferrer, A., Schultz-Rogers, L., Kaiwar, C., Kemppainen, J. L., Klee, E.
W., & Gavrilova, R. H. (2019). Three rare disease diagnoses in one
patient through exome sequencing. Cold Spring Harb Mol Case Stud, 5(6).
doi:10.1101/mcs.a004390
Firth, H. V., Richards, S. M., Bevan, A. P., Clayton, S., Corpas, M.,
Rajan, D., . . . Carter, N. P. (2009). DECIPHER: Database of Chromosomal
Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum
Genet, 84(4), 524-533. doi:10.1016/j.ajhg.2009.03.010
Grady, J. P., Pickett, S. J., Ng, Y. S., Alston, C. L., Blakely, E. L.,
Hardy, S. A., . . . McFarland, R. (2018). mtDNA heteroplasmy level and
copy number indicate disease burden in m.3243A>G
mitochondrial disease. EMBO Mol Med, 10(6). doi:10.15252/emmm.201708262
Groesser, L., Herschberger, E., Ruetten, A., Ruivenkamp, C., Lopriore,
E., Zutt, M., . . . Hafner, C. (2012). Postzygotic HRAS and KRAS
mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet,
44(7), 783-787. doi:10.1038/ng.2316
Gunning, A. C., Fryer, V., Fasham, J., Crosby, A. H., Ellard, S., Baple,
E. L., & Wright, C. F. (2021). Assessing performance of pathogenicity
predictors using clinically relevant variant datasets. J Med Genet,
58(8), 547-555. doi:10.1136/jmedgenet-2020-107003
Ioannidis, N. M., Rothstein, J. H., Pejaver, V., Middha, S., McDonnell,
S. K., Baheti, S., . . . Sieh, W. (2016). REVEL: An Ensemble Method for
Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet,
99(4), 877-885. doi:10.1016/j.ajhg.2016.08.016
Jabato, F. M., Seoane, P., Perkins, J. R., Rojano, E., Garcia Moreno,
A., Chagoyen, M., . . . Ranea, J. A. G. (2021). Systematic
identification of genetic systems associated with phenotypes in patients
with rare genomic copy number variations. Hum Genet, 140(3), 457-475.
doi:10.1007/s00439-020-02214-7
Jaganathan, K., Kyriazopoulou Panagiotopoulou, S., McRae, J. F.,
Darbandi, S. F., Knowles, D., Li, Y. I., . . . Farh, K. K. (2019).
Predicting Splicing from Primary Sequence with Deep Learning. Cell,
176(3), 535-548 e524. doi:10.1016/j.cell.2018.12.015
Kaplanis, J., Samocha, K. E., Wiel, L., Zhang, Z., Arvai, K. J.,
Eberhardt, R. Y., . . . Retterer, K. (2020). Evidence for 28 genetic
disorders discovered by combining healthcare and research data. Nature,
586(7831), 757-762. doi:10.1038/s41586-020-2832-5
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alfoldi,
J., Wang, Q., . . . MacArthur, D. G. (2020). The mutational constraint
spectrum quantified from variation in 141,456 humans. Nature, 581(7809),
434-443. doi:10.1038/s41586-020-2308-7
Kircher, M., Witten, D. M., Jain, P., O’Roak, B. J., Cooper, G. M., &
Shendure, J. (2014). A general framework for estimating the relative
pathogenicity of human genetic variants. Nat Genet, 46(3), 310-315.
doi:10.1038/ng.2892
Kohler, S., Carmody, L., Vasilevsky, N., Jacobsen, J. O. B., Danis, D.,
Gourdine, J. P., . . . Robinson, P. N. (2019). Expansion of the Human
Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids
Res, 47(D1), D1018-D1027. doi:10.1093/nar/gky1105
Kuhn, R. M., Haussler, D., & Kent, W. J. (2013). The UCSC genome
browser and associated tools. Brief Bioinform, 14(2), 144-161.
doi:10.1093/bib/bbs038
Lochmuller, H., Badowska, D. M., Thompson, R., Knoers, N. V.,
Aartsma-Rus, A., Gut, I., . . . consortium, E. U. (2018). RD-Connect,
NeurOmics and EURenOmics: collaborative European initiative for rare
diseases. Eur J Hum Genet, 26(6), 778-785. doi:10.1038/s41431-018-0115-5
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R.,
Thormann, A., . . . Cunningham, F. (2016). The Ensembl Variant Effect
Predictor. Genome Biol, 17(1), 122. doi:10.1186/s13059-016-0974-4
Miller, D. (2021). The diagnostic odyssey: our family’s story. Am J Hum
Genet, 108(2), 217-218. doi:10.1016/j.ajhg.2021.01.003
Mistry, J., Chuguransky, S., Williams, L., Qureshi, M., Salazar, G. A.,
Sonnhammer, E. L. L., . . . Bateman, A. (2021). Pfam: The protein
families database in 2021. Nucleic Acids Res, 49(D1), D412-D419.
doi:10.1093/nar/gkaa913
Monroe, G. R., Frederix, G. W., Savelberg, S. M., de Vries, T. I.,
Duran, K. J., van der Smagt, J. J., . . . van Haaften, G. (2016).
Effectiveness of whole-exome sequencing and costs of the traditional
diagnostic trajectory in children with intellectual disability. Genet
Med, 18(9), 949-956. doi:10.1038/gim.2015.200
Monroe, G. R., Frederix, G. W., Savelberg, S. M., de Vries, T. I.,
Duran, K. J., van der Smagt, J. J., . . . van Haaften, G. (2016).
Effectiveness of whole-exome sequencing and costs of the traditional
diagnostic trajectory in children with intellectual disability. Genet
Med, 18(9), 949-956. doi:10.1038/gim.2015.200
MyGene2. (2016). Website aims to accelerate gene discovery, diagnosis,
treatment: MyGene2.org fosters open sharing among families, researchers,
and clinicians. Am J Med Genet A, 170(6), 1388-1389.
doi:10.1002/ajmg.a.37746
Posey, J. E., Harel, T., Liu, P., Rosenfeld, J. A., James, R. A., Coban
Akdemir, Z. H., . . . Lupski, J. R. (2017). Resolution of Disease
Phenotypes Resulting from Multilocus Genomic Variation. N Engl J Med,
376(1), 21-31. doi:10.1056/NEJMoa1516767
Quaio, C., Moreira, C. M., Novo-Filho, G. M., Sacramento-Bobotis, P. R.,
Groenner Penna, M., Perazzio, S. F., . . . Baratela, W. (2020).
Diagnostic power and clinical impact of exome sequencing in a cohort of
500 patients with rare diseases. Am J Med Genet C Semin Med Genet,
184(4), 955-964. doi:10.1002/ajmg.c.31860
Rahit, K., & Tarailo-Graovac, M. (2020). Genetic Modifiers and Rare
Mendelian Disease. Genes (Basel), 11(3). doi:10.3390/genes11030239
Requena, F., Abdallah, H. H., Garcia, A., Nitschke, P., Romana, S.,
Malan, V., & Rausell, A. (2021). CNVxplorer: a web tool to assist
clinical interpretation of CNVs in rare disease patients. Nucleic Acids
Res, 49(W1), W93-W103. doi:10.1093/nar/gkab347
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J.,
. . . Committee, A. L. Q. A. (2015). Standards and guidelines for the
interpretation of sequence variants: a joint consensus recommendation of
the American College of Medical Genetics and Genomics and the
Association for Molecular Pathology. Genet Med, 17(5), 405-424.
doi:10.1038/gim.2015.30
Riggs, E. R., Andersen, E. F., Cherry, A. M., Kantarci, S., Kearney, H.,
Patel, A., . . . Martin, C. L. (2020). Technical standards for the
interpretation and reporting of constitutional copy-number variants: a
joint consensus recommendation of the American College of Medical
Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).
Genet Med, 22(2), 245-257. doi:10.1038/s41436-019-0686-8
Sawyer, S. L., Hartley, T., Dyment, D. A., Beaulieu, C. L.,
Schwartzentruber, J., Smith, A., . . . Boycott, K. M. (2016). Utility of
whole-exome sequencing for those near the end of the diagnostic odyssey:
time to address gaps in care. Clin Genet, 89(3), 275-284.
doi:10.1111/cge.12654
Sim, N. L., Kumar, P., Hu, J., Henikoff, S., Schneider, G., & Ng, P. C.
(2012). SIFT web server: predicting effects of amino acid substitutions
on proteins. Nucleic Acids Res, 40(Web Server issue), W452-457.
doi:10.1093/nar/gks539
Sobreira, N., Schiettecatte, F., Valle, D., & Hamosh, A. (2015).
GeneMatcher: a matching tool for connecting investigators with an
interest in the same gene. Hum Mutat, 36(10), 928-930.
doi:10.1002/humu.22844
Stenson, P. D., Mort, M., Ball, E. V., Chapman, M., Evans, K., Azevedo,
L., . . . Cooper, D. N. (2020). The Human Gene Mutation Database
(HGMD((R))): optimizing its use in a clinical diagnostic or research
setting. Hum Genet, 139(10), 1197-1207. doi:10.1007/s00439-020-02199-3
Stranneheim, H., Lagerstedt-Robinson, K., Magnusson, M., Kvarnung, M.,
Nilsson, D., Lesko, N., . . . Wedell, A. (2021). Integration of whole
genome sequencing into a healthcare setting: high diagnostic rates
across multiple clinical entities in 3219 rare disease patients. Genome
Med, 13(1), 40. doi:10.1186/s13073-021-00855-5
Swaminathan, G. J., Bragin, E., Chatzimichali, E. A., Corpas, M., Bevan,
A. P., Wright, C. F., . . . Firth, H. V. (2012). DECIPHER: web-based,
community resource for clinical interpretation of rare variants in
developmental disorders. Hum Mol Genet, 21(R1), R37-44.
doi:10.1093/hmg/dds362
Tan, A., Abecasis, G. R., & Kang, H. M. (2015). Unified representation
of genetic variants. Bioinformatics, 31(13), 2202-2204.
doi:10.1093/bioinformatics/btv112
Tavtigian, S. V., Greenblatt, M. S., Harrison, S. M., Nussbaum, R. L.,
Prabhu, S. A., Boucher, K. M., . . . ClinGen Sequence Variant
Interpretation Working, G. (2018). Modeling the ACMG/AMP variant
classification guidelines as a Bayesian classification framework. Genet
Med, 20(9), 1054-1060. doi:10.1038/gim.2017.210
Thomas, Q., Gautier, T., Marafi, D., Besnard, T., Willems, M., Moutton,
S., . . . Vitobello, A. (2021). Haploinsufficiency of ARFGEF1 is
associated with developmental delay, intellectual disability, and
epilepsy with variable expressivity. Genet Med.
doi:10.1038/s41436-021-01218-6
Whiffin, N., Minikel, E., Walsh, R., O’Donnell-Luria, A. H., Karczewski,
K., Ing, A. Y., . . . Ware, J. S. (2017). Using high-resolution variant
frequencies to empower clinical genome interpretation. Genet Med,
19(10), 1151-1158. doi:10.1038/gim.2017.26
Wright, C. F., Fitzgerald, T. W., Jones, W. D., Clayton, S., McRae, J.
F., van Kogelenberg, M., . . . study, D. D. D. (2015). Genetic diagnosis
of developmental disorders in the DDD study: a scalable analysis of
genome-wide research data. Lancet, 385(9975), 1305-1314.
doi:10.1016/S0140-6736(14)61705-0
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018). Paediatric
genomics: diagnosing rare disease in children. Nat Rev Genet, 19(5),
253-268. doi:10.1038/nrg.2017.116